Faillie, J. L., Azoulay, L. ., Patenaude, V. ., Hillaire-Buys, D. ., & Suissa, S. . (2014). Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. Bmj. http://doi.org/10.1136/bmj.g2780
J. Faillie
First name
J.
Middle name
L.
Last name
Faillie
Faillie, J. L., Filion, K. B., Patenaude, V. ., Ernst, P. ., & Azoulay, L. . (2015). Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes. Diabetes Obes Metab. http://doi.org/10.1111/dom.12431
Faillie, J. L., Yu, O. H., Yin, H. ., Hillaire-Buys, D. ., Barkun, A. ., & Azoulay, L. . (2016). Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus. JAMA Intern Med. http://doi.org/10.1001/jamainternmed.2016.1531
Abrahami, D. ., Douros, A. ., Yin, H. ., Yu, O. H., Faillie, J. L., Montastruc, F. ., … Azoulay, L. . (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Faillie, J. L., Yin, H. ., H. Y. Yu, O. ., Herrero, A. ., Altwegg, R. ., Renoux, C. ., & Azoulay, L. . (2021). Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2430